Clinical Safety and Efficacy Observation of Ex Vivo-Expanded Peripheral Blood-Derived Allogeneic NK Cells in the Treatment of Refractory or Recurrent Ovarian Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
NK Cell Therapy,NK Cell Development,NK Cell Recognition,NK Cell Activation,NK Cell Education
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined